PROGESTIN THERAPY OF ENDOMETRIAL, BREAST AND OVARIAN-CARCINOMA - A REVIEW OF CLINICAL OBSERVATIONS

被引:87
作者
KAUPPILA, A
机构
关键词
D O I
10.3109/00016348409156700
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
引用
收藏
页码:441 / 450
页数:10
相关论文
共 122 条
[1]
ALEXIEVAFIGUSCH J, 1980, CANCER, V46, P2369, DOI 10.1002/1097-0142(19801201)46:11<2369::AID-CNCR2820461111>3.0.CO
[2]
2-3
[4]
ANSFIELD FJ, 1974, CANCER, V33, P907, DOI 10.1002/1097-0142(197404)33:4<907::AID-CNCR2820330403>3.0.CO
[5]
2-Y
[6]
BEEX L, 1982, FEB INT S MEDR AC GE, P61
[7]
DO ESTROGEN AND PROGESTERONE RECEPTORS (E2R AND PR) IN METASTASIZING ENDOMETRIAL CANCERS PREDICT THE RESPONSE TO GESTAGEN THERAPY [J].
BENRAAD, TJ ;
FRIBERG, LG ;
KOENDERS, AJM ;
KULLANDER, S .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1980, 59 (02) :155-159
[8]
BERETTA G, 1982, P INT S MEDROXYPROGE, P285
[9]
BERGQVIST A, 1981, ACTA OBSTET GYN SCAN, P75
[10]
HORMONO-PROPHYLAXIS AND HORMONOTHERAPY IN TREATMENT OF ENDOMETRIAL ADENOCARCINOMA BY MEANS OF MEDROXYPROGESTERONE ACETATE [J].
BONTE, J ;
DECOSTER, JM ;
IDE, P ;
BILLIET, G .
GYNECOLOGIC ONCOLOGY, 1978, 6 (01) :60-75